Skip to content

AdaptDx Pro Testing: Embracing a New Standard of Care for AMD

Bill McPhee

Our vision has always remained constant: to revolutionize vision care by empowering primary eye care professionals with the technology and tools needed to create an AMD Center of Excellence®. Incorporating new technology into your daily workflow can seem overwhelming and complicated but our team works tirelessly to ensure dark adaptation testing with the AdaptDx Pro™ dark adaptometer is efficient and seamless.

Back to Videos

 

 

Transcript:

Our vision is to eliminate blindness caused by AMD and to accomplish that our mission is provide the technology tools and education to practitioners so that they can help patients keep as much sight as they can for their entire lives. The three key challenges that we face as a company and I would argue as an industry: the first one is scalability. Practically-speaking, when you have a tabletop instrument it’s one patient, one technician, one instrument. The second big problem we found was implementation.

Incorporating new technology into your eye care practice

Incorporating new technology into anybody’s life is complicated but when you’re incorporated into a smooth well-oiled machine like an optometry practice and you disrupt that in any way it causes problems. Staff has to change the way they do things and as human beings behavioral change is difficult. The other thing we discovered was that physicians were really interested in introducing a new standard of care but they struggled with how hard it was going to be. The head-mounted approach gives the practice a lot more flexibility about where to conduct the tests, how to conduct the tests, and with whom the test be conducted.

Making new technology convenient for patients and practices 

And finally from a patient point of view it’s just so much easier because the patient can be tested anywhere, anytime, by pretty much anyone. Historically all of the instruments in ophthalmology and optometry have been tabletop instruments. It’s kind of a legacy and as I looked at the future of optometry, it became clear to me that the footprint of instruments – diagnostic interests in particular in practice – had to get smaller. There just isn’t enough space and our current technology, while does a great job of finding disease, it could be made much more user-friendly both for patients and practitioners.

Addressing problems with new technology

So what we’ve done is we’ve tried to take the same incredibly capable technology that has 90% accuracy, miniaturize it so it can be used in a head-mounted setting. We’re launching the first in the world disease management platform for AMD – it’s got three key components that address three problems in the industry. The first component is the AdaptDx Pro which provides for the scalability and provision of services to patients in a timely and effective manner. Second is Theia. Basically Theia acts as an artificial intelligence technician on board that basically accelerates implementation. And finally the third component is Meye Practice software that allows us to provide physicians and technicians with the information they need so they can change their behavior and embrace a new standard of care for AMD.